9989 — Sundrug Co Balance Sheet
0.000.00%
- ¥479bn
- ¥460bn
- ¥802bn
- 96
- 58
- 32
- 71
Annual balance sheet for Sundrug Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | — | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 86,495 | 89,330 | 80,872 | 69,698 | 64,956 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 31,506 | 33,456 | 37,503 | 42,640 | 48,384 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 194,262 | 199,537 | 205,907 | 208,243 | 216,777 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 67,169 | 77,855 | 100,248 | 120,536 | 136,706 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 308,528 | 325,768 | 360,672 | 420,208 | 444,007 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 95,116 | 96,045 | 113,249 | 155,466 | 128,507 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 103,372 | 105,176 | 124,344 | 167,118 | 174,294 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 205,156 | 220,592 | 236,328 | 253,090 | 269,713 |
| Total Liabilities & Shareholders' Equity | 308,528 | 325,768 | 360,672 | 420,208 | 444,007 |
| Total Common Shares Outstanding |